Table 1.
Patient Characteristics | (N=43) |
---|---|
Age | 62.7 (34.5–82.8) |
Sex | |
Male | 25 (58%) |
Female | 18 (42%) |
Race | |
White | 40 (93%) |
African-American | 3 (7%) |
ECOG PS | |
0 | 23 (53%) |
1 | 20 (47%) |
Location of Lesion | |
IHCC | 27 (62%) |
EHCC | 11(26%) |
GB | 5 (12%) |
Previous Chemo | |
1 line | 28 (65%) |
2 lines | 15 (35 %) |
Gemcitabine | 42 |
Cisplatin | 40 |
Oxaliplatin | 13 |
Carboplatin | 5 |
5-FU | 13 |
Capecitabine | 2 |
Irinotecan | 2 |
Neb-Paclitaxel | 1 |
Trastuzumab | 1 |
Cetuximab | 1 |
XRT | 6 |
TACE | 2 |